Company news

OpSens Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

OpSens Announces FIRST Quarter fiscal 2022 Financial Results

January 13, 2022

OpSens to host first quarter fiscal year 2022 financial results conference call on Thursday, January 13, 2022

January 6, 2022

OpSens announces 510(k) submission to U.S. FDA for new guidewire for the TAVR procedure

December 13, 2021

Opsens to Present at the Lytham Partners Winter 2021 Investor Conference: Presentation at 11 Am (ET), Monday December 13, 2021

December 7, 2021

OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results

November 23, 2021

OpSens Successfully Completes 20-Patient in Human Clinical Study for TAVR Procedure

November 23, 2021

OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Year-End Update on Tuesday, November 23, 2021

November 17, 2021

OpSens will Participate at Stifel 2021 Virtual Healthcare Conference and Canaccord Genuity MedTech & Diagnostics Forum

November 10, 2021

OPSENS' SAVVYWIRE(TM) Featured at the Transcatheter Cardiovascular Therapeutics 2021 Annual Meeting in Orlando

November 8, 2021

OpSens Successfully Treats First Patients in Human Clinical Study for TAVR Procedure

October 13, 2021

OpSens to Present at the Lytham Partners Fall 2021 Investor Conference

September 29, 2021

OPSENS Receives Approval from Health Canada to Initiate First In-Man Clinical Study for its New Guidewire for the TAVR Procedure

September 20, 2021

OpSens Appoints Lori Chmura to its Board of Directors

September 8, 2021

OpSens Announces Third Quarter Fiscal 2021 Record Financial Results

July 13, 2021

OpSens to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesday, July 13, 2021

July 7, 2021

OpSens Solutions Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring System for Aerospace Applications, Including Civil Aircrafts

June 16, 2021

OpSens will Participate and Present at two Investment Conferences - Lytham Partners and Raymond James

June 9, 2021

OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference

May 13, 2021

OpSens Integrates its OptoWire's dPR and FFR Algorithms Within Cathmedical Cardiovascular's Picasso System in Spain

April 21, 2021

OpSens Announces Second Quarter Fiscal 2021 Financial Results and Record FFR and dPR Revenues

April 14, 2021

OpSens Awarded Innovative Technology Contract by Vizient for OptoWire III

April 7, 2021

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021

April 6, 2021

OpSens to Present at Lytham Partners Spring 2021 Investor Conference

March 22, 2021

OpSens Announces Closing of $28.75 Million Bought Deal Public Offering Including $3.75 Million Over-Allotment Option Exercised in Full

February 25, 2021

OpSens Obtains CE Marking for the OptoWire III

February 18, 2021

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER)

February 8, 2021

OpSens Inc. Announces $25 Million Bought Deal Offering

February 5, 2021

OpSens Announces First Quarter Fiscal 2021 Financial Results

January 13, 2021

OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021

January 6, 2021

OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 24, 2020

OpSens Announces Fourth Quarter and Fiscal Year 2020 Financial Results

November 19, 2020

OpSens Recognized as One of the Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500(TM)

November 18, 2020

OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020

November 12, 2020

OpSens to Present at the Virtual Fall Investor Summit on November 16

November 12, 2020

OpSens Awarded Contract by Major U.S. Group Purchasing Organization

October 14, 2020

OpSens to Present at Lytham Partners Virtual Investor Growth Conference

September 30, 2020

OpSens to Present at the LD 500 Virtual Conference

August 26, 2020

LD Micro Announces Preliminary List of Presenters for the LD-500

August 5, 2020

OpSens Announces Result for Q3 2020

July 15, 2020

OpSens - 100,000 Cases Performed with the OptoWire

May 20, 2020

OpSens Announces Q2 2020 Results

April 9, 2020

OpSens provides operational update - OpSens continues to supply essential cardiovascular solutions to patients around the world

March 24, 2020

Opsens - Election Results for the Board of Directors

January 22, 2020

Opsens Receives FDA Approval of Optowire III

January 13, 2020

Opsens - Announces Q1 2020 Results

January 13, 2020

Opsens Receives dPR Clearance from the FDA

December 19, 2019

Opsens - Record FY2019 Consolidated Revenues of $32.8 M, Up 36%, Record FFR Revenues of $20M, Up 41%

November 14, 2019

Opsens Announces Entry Into Structural Heart Market

November 5, 2019

Opsens Solutions - Strategic Order for Fiber Optic Sensors to be Deployed in New Industrial Dewatering Process

July 16, 2019

Opsens - Q3 2019 - Record Quarterly FFR Revenues of $5.2 M, Up 49%

July 11, 2019

← Newer news releases · Older news releases →

Decks

The 5 newest of 12 decks. Every deck is listed under its year.